InvestorsHub Logo
Followers 48
Posts 4291
Boards Moderated 0
Alias Born 09/08/2014

Re: mediscience post# 190

Sunday, 10/19/2014 12:29:17 PM

Sunday, October 19, 2014 12:29:17 PM

Post# of 290
The monopoly of having the only sustainable and traceable supply of KLH. If a drug is approved then only a traceable supply can be used and only Stellar has that in being the only aquaculture facility anywhere. Stellar also has patents regarding the blood extraction procedure which doesn't harm the host. One final note is the facility got a nice surprise last year when they discovered that the limpets are reproducing in the tanks. I've been in and out of Stellar since 2010 and look forward to the day when approved drugs become reality. One or two approvals would strain inventory.Three or four might not be able to be fulfilled and that would cry quite the monopoly for Stellar and opportunities for its shareholders. Remember one thing, limpets harvested in the wild can only be used for research and only a traceable and documented supply can be used in drug production.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.